The Journal of Organic Chemistry
Featured Article
intensity, ion): 160.10 (54.39, M+), 117.05 (100.00, M+ C3H7). HRMS
(EI): [M+] calcd for C12H16 160.125, found 160.125.
2H), 1.86−1.84 (d, 3H). 13C NMR (101 MHz; CDCl3) linear 2E,4Z
isomer: δ 140.5, 132.4, 129.2, 128.6, 128.4, 126.6, 125.0, 39.3, 13.4;
linear 2E,4E and unidentified olefin isomer: δ 131.6, 131.4, 130.4,
130.1, 129.5, 128.5, 127.9, 127.4, 126.7, 126.1, 126.1, 126.0, 125.98,
125.95, 39.0, 33.9, 18.4, 18.1, 13.4 (no literature 13C NMR spectrum is
available for linear 2E,4E olefin isomer). GC−MS (EI) m/z (rel
intensity, ion): 158.10 (52.92, M+), 129.10 (100.00, M+ − C2H4).
HRMS (EI): [M+] calcd for C12H14 158.120, found 158.120.
(E)-Prop-1-ene-1, 3-diyldibenzene (3a) (Table 3, Entry 2).50
Procedure A was followed with 1-phenylallyl acetate (2c) (176 mg,
1.00 mmol) and iodobenzene (167 μL, 1.50 mmol). Purification by
flash chromatography (100% hexanes) afforded 101 mg (52% yield) of
the title compound as a colorless oil; analytical data matched those
1
reported in the literature. H NMR (400 MHz; CDCl3) δ 7.41−7.24
(m, 10H), 6.50 (d, J = 15.8 Hz, 1H), 6.40 (dt, J = 15.1, 7.3 Hz, 1H),
3.59 (d, J = 6.5 Hz, 2H). 13C NMR (101 MHz; CDCl3) δ140.6, 137.9,
131.5, 129.6, 129.1, 128.9, 127.5, 126.6, 126.5, 39.8. GC−MS (EI) m/z
(rel intensity, ion): 194.10 (100.00, M+). HRMS (EI) [M+]: calcd for
C15H14 194.120, found 194.120.
(3,7-Dimethylocta-2,6-dien-1-yl)benzene (4e) (Table 3, Entry
7).53a,56,57 Procedure A was followed with geranyl acetate (214 μL,
1.00 mmol) and iodobenzene (167 μL, 1.50 mmol). Purification by
flash chromatography (100% hexanes) afforded 171 mg (80% yield) of
a mixture of the three isomers as a colorless oil. Isolated product has a
1.9:1 [linear]/[branched] ratio. The linear and branched products
were identified by GC/MS fragmentation patterns and by comparison
with literature NMR values. By NMR, the yield of linear products is
52% and the yield of branched product is 28%. Linear (E and Z)
Isomers.53a,57 1H NMR (500 MHz; CDCl3): δ 7.36−7.21 (m, 10H),
5.40−5.36 (m, 2H), 5.19−5.07 (m, 2H), 3.40 (d, J = 7.2 Hz, 4H),
2.22−2.08 (m, 8H), 1.79 (s, 3H), 1.75 (s, 3H), 1.72 (s, 6H), 1.66 (s,
3H), 1.64 (s, 3H). 13C NMR (126 MHz; CDCl3): δ 142.0 (E), 141.9
(Z), 136.4 (E), 136.3 (Z), 131.9 (Z), 131.6 (E), 128.50 (E/Z), 128.47
(E/Z), 128.45 (E/Z), 125.83 (E/Z), 125.80 (E/Z), 124.4 (E), 124.3
(Z), 124.0 (Z), 123.2 (E), 39.9 (E), 34.33 (E/Z), 34.27 (E/Z), 32.1
(Z), 26.7 (E/Z), 25.9 (E), 25.8 (Z), 25.0 (Z), 23.6 (Z), 17.9 (E), 17.8
(Z), 16.3 (E). Branched isomer:56 1H NMR (500 MHz; CDCl3): δ
7.36−7.21 (m, 5H), 6.08 (dd, J = 17.5, 10.7 Hz, 1H), 5.19−5.07 (m,
2H), 1.91−1.82 (m, 4H), 1.69 (s, 3H), 1.55 (s, 3H), 1.42 (s, 3H). 13C
NMR (126 MHz; CDCl3): δ 147.6, 147.0, 131.5, 128.2, 126.7, 125.9,
124.8, 111.9, 44.4, 41.3, 25.9, 23.4, 17.7. GC−MS (EI) m/z (rel
intensity, ion): 214.15 (9.14, M+), 123.15 (100.00, M+ - C7H7). HRMS
(EI) [M+] calcd for C16H22: 214.172; found: 214.173.
(E)-Prop-1-ene-1,3-diyldibenzene (3a) (Table 3, Entry 3).50
Procedure A was followed with (Z)-3-phenylallyl acetate (2d) (176
mg, 1 mmol) and iodobenzene (167 μL, 1.5 mmol). Purification by
flash chromatography (100% hexanes) afforded 146 mg (75% yield) of
the title compound as a colorless oil; analytical data matched those
1
reported in the literature. H NMR (400 MHz; CDCl3): δ 7.41−7.22
(m, 10H), 6.50 (d, J = 15.8 Hz, 1H), 6.40 (dt, J = 15.7, 6.7 Hz, 1H),
3.60 (d, J = 6.6 Hz, 2H). 13C NMR (101 MHz; CDCl3): δ 140.6,
137.9, 131.5, 129.6, 129.1, 128.9, 127.5, 126.6, 126.5, 39.8. GC−MS
(EI) m/z (rel intensity, ion): 194.05 (100.00, M+). HRMS (EI): [M+]
calcd for C15H14 194.110, found 194.110.
(E)-1-Cyclohexyl-3-phenylpropene (4b) (Table 3, Entry 4).50
Procedure A was followed with 3-cyclohexylallyl acetate (2e) (182
mg, 1.00 mmol) and iodobenzene (167 μL, 1.50 mmol). Purification
by flash chromatography (100% hexanes) afforded 194 mg (97%
yield) of the title compound as a colorless oil. The isolated product has
a 93:7 [linear]/[branched] ratio, as determined by GC/MS
fragmentation patterns and by comparison with literature NMR
1
data. H NMR (400 MHz; CDCl3) linear isomer: δ 7.35−7.18 (m,
5H), 5.60−5.49 (m, 2H), 3.36 (d, J = 5.8 Hz, 2H), 2.01−1.96 (m,
1H), 1.78−1.66 (m, 5H), 1.34−1.09 (m, 5H); branched isomer: δ
7.35−7.18 (m, 5H), δ 6.06−5.98 (m, 1H), δ 5.06 (d, 1H), δ5.03 (d,
1H), 2.97 (t, 1H), 1.97−2.01 (m, 1H), 1.65−1.59 (m, 3H), 1.48−1.44
(m, 1H), 1.34−1.09 (m, 5H). 13C NMR (101 MHz; CDCl3) linear
isomer: δ 141.2, 138.1, 128.5, 128.3, 126.1, 125.8, 40.7, 39.1, 33.1,
26.2, 26.1; branched isomer: δ 141.2, 138.1, 128.5, 128.3, 126.1, 125.8,
40.7, 39.1, 33.1, 26.2, 26.1 (one peak was not visible). GC−MS (EI)
m/z (rel intensity, ion): 200.10 (14.90, M+), 109.10 (100.00, M+ −
C7H7). HRMS (EI): [M+] calcd for C15H20 200.157, found 200.157.
1-(4-(2-Methylallyl)phenyl)ethanone (4c) (Table 3, Entry 5).54
Procedure A was followed with 2-methylallyl acetate (2f) (114 mg,
1.00 mmol) and 4-iodoacetophenone (369 mg, 1.50 mmol).
Purification by flash chromatography (9% ethyl acetate in hexanes)
afforded 96 mg (55% yield) of the title compound as a pale yellow oil;
analytical data matched those reported previously. 1H NMR (400
MHz; CDCl3): δ 7.93−7.91 (m, 2H), 7.30 (t, J = 7.8 Hz, 2H), 4.88 (s,
1H), 4.77 (s, 1H), 3.40 (s, 2H), 2.61 (s, 3H), 1.70 (s, 3H). 13C NMR
(101 MHz; CDCl3): δ 197.8, 145.5, 144.1, 135.3, 129.1, 128.5, 112.7,
44.6, 26.6, 22.1. GC−MS (EI) m/z (rel intensity, ion): 174.10 (15.17,
M+), 115 (100.00, M+ − CH3). HRMS (EI): [M+] calcd for C12H14O
174.105, found 174.105.
1-phenyl-2-cyclohexene (4f) (Table 3, Entry 8).53a Procedure A
was followed with cyclohex-2-en-1-yl acetate (2i) (140 mg, 1.00
mmol) and iodobenzene (167 μL, 1.50 mmol). Purification by flash
chromatography (100% hexanes) afforded 126 mg (80% yield) of the
1
title compound as a colorless oil. H NMR (500 MHz; CDCl3): δ
7.35−7.22 (m, 5H), 5.95−5.91 (m, 1H), 5.78−5.74 (m, 1H), 3.45 (td,
J = 5.1, 2.5 Hz, 1H), 2.15−2.03 (m, 3H), 1.81−1.77 (m, 1H), 1.69−
1.55 (m, 2H). 13C NMR (101 MHz; CDCl3): δ 146.7, 130.2, 128.4,
128.3, 127.8, 126.0, 41.9, 32.7, 25.1, 21.2. GC−MS (EI) m/z (rel
intensity, ion): 158.10 (100.00, M+). HRMS (EI): [M+] calcd for
C12H14 158.120, found 158.110. NMR data matched those previously
reported.
(E)-But-1-ene-1,3-diyldibenzene (4g) (Table 3, Entry 9).53a
Procedure A was followed with but-1-ene-1,3-diyldibenzene (2j)
(190 mg, 1.00 mmol) and iodobenzene (167 μL, 1.50 mmol).
Purification by flash chromatography (100% hexanes) afforded 152 mg
1
(73% yield) of the title compound as a colorless oil. H NMR (400
MHz; CDCl3): δ 7.41−7.23 (m, 10H), 6.48−6.39 (m, 2H), 3.71−3.65
(m, 1H), 1.51 (d, J = 7.0 Hz, 3H). 13C NMR (101 MHz; CDCl3): δ
145.8, 137.7, 135.4, 128.7, 128.5, 127.4, 127.2, 126.4, 126.3, 42.7, 21.4
GC−MS (EI) m/z (rel intensity, ion): 208.10 (66.46, M+), 115
(100.00, M+ − C7H8). HRMS (EI): [M+] calcd for C16H16 208.125,
found 208.125. NMR data matched those previously reported.
Procedure D: Allylic Acetates with Alkyl Halides in a Nitrogen
Glovebox. A 1 dram vial was charged with NiCl2(dme) (10.6 mg,
0.0483 mmol), 4,4′,4″-tri-tert-butyl-2,2′:6′,2″-terpyridine (20.0 mg,
(0.0498 mmol), and DMA (500 μL), a Teflon-coated magnetic stirbar
was then added, and the reaction mixture was stirred for 5−10 min
before the sequential addition of allylic acetate (1.3 mmol), secondary
alkyl halide (1.0 mmol), THF (1500 μL), and manganese powder
(109.6 mg, 2.00 mmol). The vial was then capped with a screw cap
with a PTFE-faced silicone septum. The reaction was then treated as in
procedure A (vide supra).
(2E,4E)-Hexa-2,4-dien-1-ylbenzene (4d) (Table 3, Entry 6).55
Procedure A was followed with (2E, 4E)-hexa-2,4-dien-1-yl acetate
(2g) (140 mg, 1.00 mmol) and iodobenzene (167 μL, 1.50 mmol).
Purification by flash chromatography (100% hexanes) afforded 103 mg
(65% yield) of the title compound as a colorless oil. Product was a
mixture of olefin isomers: 6.9:1:1 [2E,4E]/[2E,4Z]/[unidentified
olefin isomer]. Olefin isomer ratio and identity were assigned based
upon GC/MS fragmentation patterns and by comparison to previously
reported NMR spectra (1H and 13C). We assigned one isomer as
2E,4E in analogy to the other products. 1H NMR (400 MHz; CDCl3)
linear 2E,4E isomer:56 δ 7.34−7.21 (m, 5H), 6.11−6.08 (m, 2H),
5.76−5.65 (m, 2H), 3.44 (d, J = 6.9 Hz, 2H), 1.78 (d, J = 6.2 Hz, 3H);
linear 2E,4Z isomer:57 δ 7.34−7.21 (m, 5H), 6.52−6.43 (dd, 1H),
6.11−6.08 (t, 1H), 5.76−5.65 (m, 1H), 5.51−5.46 (m, 1H), 3.50 (d, J
= 7.0 Hz,), 1.78 (dd, 3H); unidentified olefin isomer: δ 7.34−7.21 (m,
5H), 6.11−6.08 (m, 2H), 5.76−5.65 (m, 2H), 3.56 (d, J = 7.4 Hz,
Procedure E: Allylic Acetates with Alkyl Halides on the Benchtop
under Argon. As in procedure D, but set up on the bench, without
care to exclude air or moisture. Once the reaction was capped, the
reaction mixture was sparged with Ar gas for 1 min, followed by a
9997
dx.doi.org/10.1021/jo302086g | J. Org. Chem. 2012, 77, 9989−10000